North Vancouver School District
the natural place to learn©
News Item


Anaphylaxis - Recall of Allerject epinephrine auto-injectors

November 02, 2015

​"Sanofi-aventis Canada Inc., in consultation with Health Canada, is recalling all lots of Allerject (0.15 mg/0.15 mL and 0.3 mg/0.3 mL strength epinephrine auto-injectors) from the Canadian market. This recall is due to issues that may potentially affect the delivery of the required amount of the drug, epinephrine."

More detailed information is available on the Health Canada website and Sanofi Canada website


Vancouver Coastal Health
On Call Nurse